Trial intelligence / Profile preview

Shan 5 vs Easy Five Interchangeability in Infants

NCT00674908Phase 4Completed

Sponsor
Shantha Biotechnics
Start
Mar 2008
Primary completion
Mar 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Shan5 in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by Shantha Biotechnics. Started Mar 2008; status: completed.

02

Drugs

Shan5
03

Conditions

diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)

Beyond the preview

Go deeper on NCT00674908.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00674908.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call